SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX)
NBIX 135.30+2.3%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. John M. de Castro who wrote (31)6/19/1997 6:25:00 PM
From: B.D.   of 1834
 
As a followup, according to insidertrader.com, three Neurocrine insiders sold 7,936 shares (worth $77,392) at an average price of 9.75 during the month of May.

Enough for all three to buy nice Land Rover Discovery's, but not enough for all three to buy Range Rovers, which are much nicer. :-)

But seriously, these sales must represent the third lockup expiry that Dr. de C. referred to, no?

They seem like pretty nominal sales to me, in the long run.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News